Designer exosomes enabling tumor targeted efficient chemo/gene/photothermal therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Exosomes are emerging as versatile platforms for cancer diagnosis and therapy.
• Integrating multiple therapeutic strategies with exosome-based delivery can enhance clinical outcomes and minimize side effects.

Purpose of the Study:

• To develop a designer exosome platform for combined chemo/gene/photothermal therapy in cancer treatment.
• To evaluate the efficacy of this multi-modal approach in preclinical cancer models.

Main Methods:

• Designer exosomes were loaded with doxorubicin (DOX) and coated with magnetic nanoparticles conjugated with molecular beacons targeting miR-21.
• External magnetic fields guided exosome accumulation at tumor sites.
• Near-infrared (NIR) radiation induced hyperthermia and triggered cargo release for imaging and gene silencing.

Main Results:

• The engineered exosomes (Exo-DOX-Fe3O4@PDA-MB) achieved 91.04% cancer cell death under NIR irradiation.
• Animal models showed a 97.57% reduction in tumor size using the magnetic field-guided, multi-modal therapy.

Conclusions:

• Designer exosome-mediated multi-modal therapy is a promising platform for precision cancer nanomedicine.
• This approach offers a potential strategy for improved cancer treatment with targeted delivery and combined therapeutic effects.